Filter Results:
(763)
Show Results For
- All HBS Web
(1,408)
- People (2)
- News (339)
- Research (763)
- Events (2)
- Multimedia (5)
- Faculty Publications (392)
Show Results For
- All HBS Web
(1,408)
- People (2)
- News (339)
- Research (763)
- Events (2)
- Multimedia (5)
- Faculty Publications (392)
Sort by
- Summer 2021
- Article
The Cost and Evolution of Quality at Cipla Ltd, 1935–2016
By: Muhammad H. Zaman and Tarun Khanna
This article examines the evolution of Indian pharmaceutical manufacturer Cipla towards producing drugs that met the quality standards of European and U.S. regulators. It employs new research in Cipla’s corporate archives, the Creating Emerging Markets database, and... View Details
Keywords: Cipla; Pharmaceuticals; Drug Quality; Generics; Quality; Standards; Information Technology; Cost; Organizational Culture; Business History; Pharmaceutical Industry; India
Zaman, Muhammad H., and Tarun Khanna. "The Cost and Evolution of Quality at Cipla Ltd, 1935–2016." Business History Review 95, no. 2 (Summer 2021): 249–274.
- 17 Feb 2022
- Book
When Employees Feel a Sense of Purpose, Companies Succeed
oversight on the part of managers. Individuals voluntarily regulate themselves, refraining from behaviors that clash with the culture. Over the past few decades, many corporate leaders have sought to build strong cultures that define... View Details
Keywords: by Ranjay Gulati
- January 2018 (Revised April 2021)
- Case
Capital Allocation at HCA
By: W. Carl Kester and Emily R. McComb
In early 2017, HCA Holdings, an investor-owned hospital management company, faced a strategically important capital allocation decision. After the exit of its private equity sponsors in 2016, HCA had to determine how best to allocate its substantial annual free cash... View Details
Keywords: Capital Allocation; Cash Distribution Policy; Dividends; Share Repurchases; Growth Strategy And Execution; Growth Investing; Capital Expenditures; Debt Management; Debt Reduction; Debt Policy; Hospital Management; Investor-owned Hospital Chains; Capital Budgeting; Capital Structure; Cash Flow; Corporate Finance; Decision Choices and Conditions; Health Industry; United States
Kester, W. Carl, and Emily R. McComb. "Capital Allocation at HCA." Harvard Business School Case 218-039, January 2018. (Revised April 2021.)
- 08 Sep 2015
- Research & Ideas
Knowledge Transfer: You Can't Learn Surgery By Watching
corporate roles is to improve upon traditional vicarious learning models. ©iStock.com/cacaroot Instead, Myers envisions a model of coactive vicarious learning. “The major shift theoretically is moving from a language of transfer, of... View Details
- 24 Jan 2017
- First Look
First Look at New Research: January 24, 2017
Yoshimi Anzai, Marta E. Heilbrun, Derek Haas, Luca Boi, Kirk Moshre, Satoshi Minoshima, and Vivian S. Lee Abstract—The lack of understanding the true costs (not charges) of delivering health care services poses tremendous challenges in... View Details
Keywords: Sean Silverthorne
- October 2012 (Revised July 2013)
- Case
Olympus (A)
By: Jay W. Lorsch, Suraj Srinivasan and Kathleen Durante
As 2012 approached, the woes of the financial crisis seemed to be fading, companies were resuming business as usual, and some of the scrutiny on corporate governance practices began to recede as well. That is until another major financial scandal emerged in Japan in... View Details
Lorsch, Jay W., Suraj Srinivasan, and Kathleen Durante. "Olympus (A) ." Harvard Business School Case 413-040, October 2012. (Revised July 2013.)
- November 2020
- Case
Valuing Celgene's CVR
By: Benjamin C. Esty and Daniel Fisher
When Bristol-Myers Squibb (BMS) acquired Celgene Corporation in November 2019, Celgene shareholders received cash, BMS stock, and a contingent value right (CVRs) that would pay $9 if the U.S. Food and Drug Administration (FDA) approved three of Celgene’s late stage... View Details
Keywords: Mergers and Acquisitions; Value; Valuation; Judgments; Decision Making; Cash Flow; Financial Instruments; Cognition and Thinking; Pharmaceutical Industry; Biotechnology Industry; United States
Esty, Benjamin C., and Daniel Fisher. "Valuing Celgene's CVR." Harvard Business School Case 221-031, November 2020.
- December 2004 (Revised March 2007)
- Case
Cutlass Capital, L.P.
By: Richard G. Hamermesh and Brian DeLacey
David Hetz and Jon Osgood are forming a new venture capital fund in 2001 to invest in health care start-ups. Describes their fundraising activities at a time when venture capital investing has reached an all-time high. Although their background skills and experiences... View Details
Keywords: Venture Capital; Negotiation Process; Entrepreneurship; Investment Funds; Health Care and Treatment; Business Startups; Health Industry; United States
Hamermesh, Richard G., and Brian DeLacey. "Cutlass Capital, L.P." Harvard Business School Case 805-075, December 2004. (Revised March 2007.)
- April 2013
- Case
Southfield Packaging
By: Michael Beer and Alisa Zalosh
Southfield Packaging provides packaging materials and services to medical device manufacturers. The case examines the relationship between a corporate vice president, Mark Sanders, and one of his direct reports, Regional Manager Frank Belby. Sanders' preparation for... View Details
Keywords: Rank and Position; Performance Evaluation; Problems and Challenges; Management Teams; Medical Devices and Supplies Industry; Distribution Industry; Service Industry
Beer, Michael, and Alisa Zalosh. "Southfield Packaging." Harvard Business School Brief Case 913-562, April 2013.
- 2013
- Case
Advanced Leadership Pathways: Laurent Adamowicz and Bon'App
By: Rosabeth M. Kanter, Juliane Calingo Schwetz and Patricia Bissett Higgins
After a successful career as Chairman and CEO of Paris-based luxury food company, Fauchon, Laurent Adamowicz, sought to reduce obesity and improve health outcomes. Adamowicz created a mobile application to provide consumers with more accessible and interpretable... View Details
Keywords: Nutritional Information; Obesity; Weight Loss; App Development; Business Startups; Nutrition; Health; Information; Mobile and Wireless Technology; Entrepreneurship; Social Enterprise; Health Industry; Health Industry
Kanter, Rosabeth M., Juliane Calingo Schwetz, and Patricia Bissett Higgins. "Advanced Leadership Pathways: Laurent Adamowicz and Bon'App." Harvard Business Publishing Case 314-028, 2013.
- 21 Feb 2005
- Op-Ed
Is Business Management a Profession?
Repeated and, as of this writing, ongoing revelations of corporate wrongdoing over the past two years have eroded public trust in business institutions and executives to levels not seen in decades. A recent Gallup poll indicates that... View Details
- January 1993 (Revised October 1993)
- Case
Medtronic, Inc.
In 1991, Bill George, CEO of Medtronic, the world's largest manufacturer of pacemakers, was evaluating his strategic options in light of the changing economic environment. In the United States, Europe, and Japan, governments were considering regulatory changes to... View Details
Keywords: Diversification; Corporate Strategy; Health Care and Treatment; Policy; Medical Devices and Supplies Industry
Goodman, John B., and Patrick Moreton. "Medtronic, Inc." Harvard Business School Case 793-058, January 1993. (Revised October 1993.)
- August 1983 (Revised June 1986)
- Case
Johnson & Johnson (A)
By: Francis Aguilar
Describes the Johnson & Johnson culture and the corporate systems, structures, and procedures which reflect and promote it. The principal teaching objectives are to gain an understanding of the impact a strong culture can have on strategic decisions and to consider how... View Details
Keywords: Organizational Culture; Management Systems; Organizational Structure; Business Growth and Maturation; Corporate Strategy; Growth Management; Health Care and Treatment; Health Industry
Aguilar, Francis. "Johnson & Johnson (A)." Harvard Business School Case 384-053, August 1983. (Revised June 1986.)
- February 1999
- Case
Lifeline Systems, Inc. (B)
By: H. Kent Bowen and Marilyn Matis
In 1997, Lifeline Systems continues to grow its service business to $32 million, 56% of the company's total revenues. More local hospital Lifeline programs turn over their monitoring service to Lifeline Central, expanding the company's subscriber base by 30%. The... View Details
Keywords: Health Care and Treatment; Information Technology; Expansion; Cost Management; Growth and Development Strategy; Partners and Partnerships; Change; Customer Relationship Management; Service Operations; Age; Investment; Health Industry; Health Industry; Cambridge; Boston
Bowen, H. Kent, and Marilyn Matis. "Lifeline Systems, Inc. (B)." Harvard Business School Case 699-038, February 1999.
- May 2020
- Case
Big Boom Beverages: Fight or Flight?
By: Stephen A. Greyser and William Ellet
Four college friends market a beverage that combines ingredients like those in a drink they consumed in college bars. It includes a caffeinated energy drink, malt liquor, and a soft drink flavoring. They launch the business, Big Boom Beverages (BBB), with their own... View Details
Keywords: Alcoholic Beverages; Energy Drinks; Regulation; Entrepreneurship; Ethics; Marketing Communications; Corporate Social Responsibility and Impact; Reputation; Communication Strategy; Decision Making
Greyser, Stephen A., and William Ellet. "Big Boom Beverages: Fight or Flight?" Harvard Business School Brief Case 920-557, May 2020.
- September 2003
- Case
Allscripts, Inc.
By: William A. Sahlman and Laurence E. Katz
Describes a set of decisions confronting an entrepreneurial team that is considering taking managerial control of Allscripts, a health care venture. The company has gone through nine rounds of external financing and has changed its business model several times. View Details
Keywords: Business Model; Business or Company Management; Venture Capital; Corporate Entrepreneurship; Health Care and Treatment; Corporate Finance; Health Industry
Sahlman, William A., and Laurence E. Katz. "Allscripts, Inc." Harvard Business School Case 804-053, September 2003.
- Research Summary
Overview
Professor Sherman's research has long focused on financial reporting, performance measurement/management, and financial literacy issues facing corporate management and Boards of Directors in global businesses. He also actively studies methods to improve productivity in... View Details
- April 2007 (Revised March 2008)
- Case
Dr. Iqbal Survé at Sekunjalo Investment Group (A)
By: Linda A. Hill and Emily Stecker
Dr. Iqbal Surve, a self-described "medical doctor, philanthropist, and social entrepreneur," was born in 1963 and grew up in poverty, like virtually all non-white South Africans during apartheid. During the 1970s and 1980s, he served in leadership positions in the ANC,... View Details
Keywords: Crime and Corruption; Social Entrepreneurship; Investment; Leadership; Corporate Social Responsibility and Impact; Partners and Partnerships; South Africa
Hill, Linda A., and Emily Stecker. "Dr. Iqbal Survé at Sekunjalo Investment Group (A)." Harvard Business School Case 407-019, April 2007. (Revised March 2008.)
- March 2010 (Revised June 2010)
- Case
Whose Money Is It Anyway? (A)
By: V.G. Narayanan, Richard G. Hamermesh and Rachel Gordon
The Brigham and Women's Physician's Organization (BWPO) and its corporate parent disagree over who has jurisdiction over significant legacy funds. Are they controlled by the BWPO or do they belong to BWPO's corporate parent? The BWPO and its corporate parent must... View Details
Keywords: Accounting; Investment Funds; Governance Controls; Agreements and Arrangements; Boundaries; Health Industry
Narayanan, V.G., Richard G. Hamermesh, and Rachel Gordon. "Whose Money Is It Anyway? (A)." Harvard Business School Case 810-008, March 2010. (Revised June 2010.)
- 31 Jul 2018
- First Look
New Research and Ideas, July 31, 2018
forthcoming Journal of Medical Internet Research Reimagining Health Data Exchange: An Application Programming Interface-Enabled Roadmap for India By: Balsari, Satchit, Alexander Fortenko MD, MPH, Joaquin A. Blaya PhD, Adrian Gropper MD,... View Details
Keywords: Dina Gerdeman